National Law Firm Files Suit on Behalf of Two DePuy ASR Hip Implant Recipients

National Law Firm Files Suit on Behalf of Two DePuy ASR Hip Implant RecipientsTwo more people who’ve suffered serious injuries blamed on the defective and recalled DePuy Orthopaedics ASR hip implant are the latest to join a growing federal class-action lawsuit against the medical device firm and its parent company, Johnson & Johnson.

A 57-year-old Virginia man and a 60-year-old Georgia woman are being represented by the law firm of Parker Waichman LLP and are among thousands to join the lawsuit alleging the ASR hip implant’s defective design is prone to early failure, risk of serious injuries, and likely to require revision and replacement surgeries to correct the problems it causes.

In a release from the firm announcing the filing of the lawsuits in U.S. District Court for the Northern District of Ohio. The federal court is the setting for a growing Multidistrict Litigation against DePuy and Johnson & Johnson (DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation).

Included in the latest filings from Parker Waichman is a Virginia man who was implanted with the DePuy ASR implant on his left hip in January 2008. He was implanted on the right side in June of that year. In February and March 2012, he found himself back on the surgeon’s table having each implant replaced after enduring four years of pain and complications blamed on the devices.

Like many others who’ve received the DePuy ASR hip implant, the Virginia man suffered countless complications in his short time with the devices, including pain, inflammation, nerve damage, and most seriously, elevated and toxic levels of the metals cobalt and chromium.

Similar claims are made by the Georgia woman who is also being represented by Parker Waichman. The release from the firm notes the woman received a DePuy ASR hip implant in November 2007 and endured pain and toxic build-up of cobalt and chromium over nearly four full years before it was removed in September of last year, about a year after it was part of a global recall issued by DePuy.

Thousands of people worldwide have made similar allegations against the defective hip implant. Numerous post-market studies have shown these implants are prone to early failure in as many as 13 percent of the people who received them. Some studies suggest the early failure rate could be higher. Despite this, the road to an eventual replacement surgery is painful and marked with visits to the doctor and revision surgeries to correct early problems caused by the DePuy ASR hip.

Recipients of the device have reported hearing popping and creaking at the site of the implant. These noises are often accompanied by pain and inflammation. In some cases, the device has completely failed unexpectedly, requiring immediate surgery. More serious however, is the overall concept of the ASR hip implant and others which rely on a metal-on-metal design. Through normal wear-and-tear of the hip implant, small metal particles are likely to be shaved off the joint surfaces and dispersed into the bloodstream and nearby tissues and muscles.

Many recipients, like those represented by Parker Waichman in the class-action lawsuit, have recently found they are suffering from toxic build-up of the metals cobalt and chromium, a condition that can cause muscle damage, death of surrounding tissues, accumulations of the metal in the body, organ damage, and eventual organ failure.

This entry was posted in Defective Medical Devices, Depuy and tagged . Bookmark the permalink.

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.